Use of slow-acting symptomatic drugs in osteoarthritis. The effectiveness of the combination of glucosamine and chondroitin in the light of the evidence
Medycyna Faktów · 2021
DOI: 10.24292/01.mf.0121.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medycyna Faktów, 2021. Verfasst von Witold Tłustochowicz.
Abstract (Originalsprache)
Treatment of osteoarthritis requires the use of drugs that will slow down the destruction of articular cartilage and reduce joint pain. Slow-acting symptomatic medications are often used in daily practice. The most frequently used and considered the most effective preparations are glucosamine and chondroitin. High-quality studies have shown that the combination of this both substances is effective in slowing the progression of the disease and reducing pain, and is also safe, even with prolonged use.
Zitieren
APA
Tłustochowicz, W. (2021). Use of slow-acting symptomatic drugs in osteoarthritis. The effectiveness of the combination of glucosamine and chondroitin in the light of the evidence. Medycyna Faktów. https://doi.org/10.24292/01.mf.0121.15
Vancouver
Tłustochowicz W. Use of slow-acting symptomatic drugs in osteoarthritis. The effectiveness of the combination of glucosamine and chondroitin in the light of the evidence. Medycyna Faktów. 2021. doi:10.24292/01.mf.0121.15
BibTeX
@article{Tustochowicz2021,
author = {Tłustochowicz, Witold},
title = {Use of slow-acting symptomatic drugs in osteoarthritis. The effectiveness of the combination of glucosamine and chondroitin in the light of the evidence},
journal = {Medycyna Faktów},
year = {2021},
doi = {10.24292/01.mf.0121.15}
}
EUVIMED